1. Academic Validation
  2. USP1/UAF1-stabilized METTL3 promotes reactive astrogliosis and improves functional recovery after spinal cord injury through m6A modification of YAP1 mRNA

USP1/UAF1-stabilized METTL3 promotes reactive astrogliosis and improves functional recovery after spinal cord injury through m6A modification of YAP1 mRNA

  • J Neurosci. 2023 Jan 17;JN-RM-1209-22. doi: 10.1523/JNEUROSCI.1209-22.2023.
Xuhui Ge 1 Wu Ye 1 Yufeng Zhu 1 Min Cui 2 Jiawen Zhou 3 Chenyu Xiao 2 Dongdong Jiang 4 Pengyu Tang 1 Jiaxing Wang 1 Zhuanghui Wang 1 Chengyue Ji 1 Xuhui Zhou 5 Xiaojian Cao 6 Wei Liu 7 Weihua Cai 6
Affiliations

Affiliations

  • 1 Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu, China.
  • 2 Department of Human Anatomy, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
  • 3 Department of Pharmacology, China Pharmaceutical University, Nanjing, 211198, China.
  • 4 Department of Orthopedics, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210006, Jiangsu, China.
  • 5 Department of Orthopedics, Second Affiliated Hospital of Naval Medical University, Shanghai, 200003, China.
  • 6 Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu, China. [email protected] [email protected] [email protected].
  • 7 Department of Orthopedics, Second Affiliated Hospital of Naval Medical University, Shanghai, 200003, China. [email protected] [email protected] [email protected].
Abstract

RNA N6-methyladenosine (m6A) modification is involved in diverse biological processes. However, its role in spinal cord injury (SCI) is poorly understood. The m6A level increases in injured spinal cord, and METTL3, which is the core subunit of methyltransferase complex, is upregulated in reactive astrocytes, and further stabilized by the USP1/UAF1 complex after SCI. The USP1/UAF1 complex specifically binds to and subsequently removes K48-linked ubiquitination of the METTL3 protein to maintain its stability after SCI. Moreover, conditional knockout of astrocytic METTL3 in both sexes of mice significantly suppressed reactive astrogliosis after SCI, thus resulting in widespread infiltration of inflammatory cells, aggravated neuronal loss, hampered axonal regeneration, and impaired functional recovery. Mechanistically, the YAP1 transcript was identified as a potential target of METTL3 in astrocytes. METTL3 could selectively methylate the 3'-UTR region of the YAP1 transcript, which subsequently maintains its stability in an IGF2BP2-dependent manner. In vivo, YAP1 overexpression by adeno-associated virus-YAP1 injection remarkably contributed to reactive astrogliosis and partly reversed the detrimental effects of METTL3 knockout on functional recovery after SCI. Furthermore, we found that the methyltransferase activity of METTL3 plays an essential role in reactive astrogliosis and motor repair, whereas METTL3 mutant without methyltransferase function failed to promote functional recovery after SCI. Our study reveals the previously unreported role of METTL3-mediated m6A modification in SCI and might provide a potential therapy for SCI.SIGNIFICANCE STATEMENT:Spinal cord injury is a devastating trauma of the central nervous system involving motor and sensory impairments. However, epigenetic modification in spinal cord injury is still unclear. Here, we propose an m6A regulation effect of astrocytic METTL3 following spinal cord injury and we further characterize its underlying mechanism, which might provide promising strategies for spinal cord injury treatment.

Figures
Products